Tharimmune, Inc. - Common Stock (THAR)
2.9100
-0.6900 (-19.17%)
NASDAQ · Last Trade: Sep 22nd, 6:48 PM EDT
Stay up-to-date with the latest market trends one hour before the close of the markets on Monday. Explore the top gainers and losers during today's session in our detailed report.
Via Chartmill · September 22, 2025
Via Benzinga · September 22, 2025
Looking for insights into the US markets in the middle of the day on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · September 22, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · September 22, 2025
Via Benzinga · September 22, 2025
Via Benzinga · September 22, 2025
Via Benzinga · September 19, 2025
Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics.
Via Chartmill · September 19, 2025
Via Benzinga · August 29, 2025
Via Benzinga · August 29, 2025
Via Benzinga · August 28, 2025
Via Benzinga · August 26, 2025
Tharimmune shares are trading lower Tuesday after the company announced it has entered into a $5.3 million securities purchase agreement.
Via Benzinga · August 26, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
Via Chartmill · August 25, 2025
Shares of Tharimmune are surging in Monday afternoon trading. The company last week announced promising simulation results for its lead clinical asset, TH104.
Via Benzinga · August 25, 2025
Via Benzinga · August 25, 2025
Which stocks have an unusual volume on Monday?
Via Chartmill · August 25, 2025
Intrigued by the market activity in the middle of the day on Monday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · August 25, 2025
Shares of Tharimmune are surging Thursday afternoon. The company on Wednesday announced positive results from a simulation analysis of its lead clinical asset, TH104.
Via Benzinga · August 21, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via Chartmill · August 21, 2025
Thursday's session is buzzing with activity. Check out the stocks that are attracting the most attention and driving market activity!
Via Chartmill · August 21, 2025
Via Benzinga · August 21, 2025
In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
Via Chartmill · August 21, 2025
Keep an eye on the top gainers and losers in Thursday's session, as they reflect the most notable price movements.
Via Chartmill · August 21, 2025
Let's have a look at what is happening on the US markets on Thursday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · August 21, 2025